price
CL
NASDAQ · CLLS
Cellectis S.A.
Healthcare · Biotechnology
$1.17
Down-$0.09 (-7.14%)
Updated Oct 30, 2026, 8:45 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 523.7M
- P/E ratio
- -8.66
- Dividend yield
- 0.00%
- 52-week range
- $0.88 – $4.55
- Volume
- 26.66K
- Avg. volume
- 146.61K
Price performance · CLLS
CLLS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
CLLS closed at $1.17 after 21 trading sessions, down 16.43% for the selected period.
- Last close
- $1.17
- Period change
- -16.43%
- Period low
- $0.93
- Period high
- $1.43
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $1.22 | $1.23 | $1.15 | $1.17 | 26.66K |
| Oct 28, 2026 | $1.10 | $1.28 | $1.0825 | $1.26 | 256.57K |
| Oct 27, 2026 | $0.9632 | $1.05 | $0.9632 | $1.05 | 78.3K |
| Oct 26, 2026 | $0.98 | $1.01 | $0.9309 | $0.9665 | 45.34K |
| Oct 23, 2026 | $1.00 | $1.0175 | $0.959 | $0.98 | 13.63K |
| Oct 22, 2026 | $0.97 | $1.0099 | $0.9177 | $0.975 | 129.35K |
| Oct 21, 2026 | $1.07 | $1.08 | $0.9106 | $0.9685 | 282.1K |
| Oct 20, 2026 | $0.94 | $1.03 | $0.93 | $0.99 | 281.75K |
| Oct 19, 2026 | $1.04 | $1.04 | $0.8808 | $0.9255 | 224.84K |
| Oct 16, 2026 | $1.12 | $1.12 | $1.03 | $1.04 | 81.37K |
| Oct 15, 2026 | $1.14 | $1.14 | $1.09 | $1.105 | 101.43K |
| Oct 14, 2026 | $1.12 | $1.1499 | $1.10 | $1.12 | 99.08K |
| Oct 13, 2026 | $1.175 | $1.175 | $1.09 | $1.10 | 54.42K |
| Oct 12, 2026 | $1.25 | $1.28 | $1.14 | $1.18 | 122.57K |
| Oct 9, 2026 | $1.27 | $1.29 | $1.25 | $1.26 | 75.76K |
| Oct 8, 2026 | $1.28 | $1.3061 | $1.2205 | $1.25 | 106.83K |
| Oct 7, 2026 | $1.35 | $1.40 | $1.33 | $1.34 | 62.46K |
| Oct 6, 2026 | $1.42 | $1.44 | $1.37 | $1.40 | 75.79K |
| Oct 5, 2026 | $1.43 | $1.4369 | $1.38 | $1.41 | 37.27K |
| Oct 2, 2026 | $1.45 | $1.4729 | $1.42 | $1.43 | 47.51K |
| Oct 1, 2026 | $1.47 | $1.50 | $1.40 | $1.40 | 140.74K |
Latest CLLS news
The latest Smart Investors Daily articles mentioning CLLS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…